| N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells JK Lee, JW Phillips, BA Smith, JW Park, T Stoyanova, EF McCaffrey, ... Cancer cell 29 (4), 536-547, 2016 | 367 | 2016 |
| The exosome total isolation chip F Liu, O Vermesh, V Mani, TJ Ge, SJ Madsen, A Sabour, EC Hsu, ... ACS nano 11 (11), 10712-10723, 2017 | 329 | 2017 |
| Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer MA Rice, SV Malhotra, T Stoyanova Frontiers in oncology 9, 801, 2019 | 304 | 2019 |
| Phosphoproteome integration reveals patient-specific networks in prostate cancer JM Drake, EO Paull, NA Graham, JK Lee, BA Smith, B Titz, T Stoyanova, ... Cell 166 (4), 1041-1054, 2016 | 222 | 2016 |
| Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer A Ghoochani, EC Hsu, M Aslan, MA Rice, HM Nguyen, JD Brooks, ... Cancer research 81 (6), 1583-1594, 2021 | 186 | 2021 |
| Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells T Stoyanova, AR Cooper, JM Drake, X Liu, AJ Armstrong, KJ Pienta, ... Proceedings of the National Academy of Sciences 110 (50), 20111-20116, 2013 | 183 | 2013 |
| Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression JM Drake, NA Graham, T Stoyanova, A Sedghi, AS Goldstein, H Cai, ... Proceedings of the National Academy of Sciences 109 (5), 1643-1648, 2012 | 179 | 2012 |
| Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling T Stoyanova, AS Goldstein, H Cai, JM Drake, J Huang, ON Witte Genes & development 26 (20), 2271-2285, 2012 | 153 | 2012 |
| Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets JM Drake, NA Graham, JK Lee, T Stoyanova, CM Faltermeier, S Sud, ... Proceedings of the National Academy of Sciences 110 (49), E4762-E4769, 2013 | 126 | 2013 |
| Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1 EC Hsu, MA Rice, A Bermudez, FJG Marques, M Aslan, S Liu, ... Proceedings of the National Academy of Sciences 117 (4), 2032-2042, 2020 | 114 | 2020 |
| Gold Nanoclusters for NIR‐II Fluorescence Imaging of Bones D Li, Q Liu, Q Qi, H Shi, EC Hsu, W Chen, W Yuan, Y Wu, S Lin, Y Zeng, ... Small 16 (43), 2003851, 2020 | 109 | 2020 |
| DDB2 decides cell fate following DNA damage T Stoyanova, N Roy, D Kopanja, S Bagchi, P Raychaudhuri Proceedings of the National Academy of Sciences 106 (26), 10690-10695, 2009 | 107 | 2009 |
| Low CD38 identifies progenitor-like inflammation-associated luminal cells that can initiate human prostate cancer and predict poor outcome X Liu, TR Grogan, H Hieronymus, T Hashimoto, J Mottahedeh, D Cheng, ... Cell reports 17 (10), 2596-2606, 2016 | 105 | 2016 |
| Cul4A is essential for spermatogenesis and male fertility D Kopanja, N Roy, T Stoyanova, RA Hess, S Bagchi, P Raychaudhuri Developmental biology 352 (2), 278-287, 2011 | 96 | 2011 |
| Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells AS Goldstein, T Stoyanova, ON Witte Molecular oncology 4 (5), 385-396, 2010 | 87 | 2010 |
| DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response T Stoyanova, N Roy, D Kopanja, P Raychaudhuri, S Bagchi Cell Cycle 8 (24), 4067-4071, 2009 | 65 | 2009 |
| The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1 T Stoyanova, T Yoon, D Kopanja, MB Mokyr, P Raychaudhuri Molecular and Cellular Biology, 2008 | 60 | 2008 |
| Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer T Stoyanova, M Riedinger, S Lin, CM Faltermeier, BA Smith, KX Zhang, ... Proceedings of the National Academy of Sciences 113 (42), E6457-E6466, 2016 | 57 | 2016 |
| Loss of Notch1 activity inhibits prostate cancer growth and metastasis and sensitizes prostate cancer cells to antiandrogen therapies MA Rice, EC Hsu, M Aslan, A Ghoochani, A Su, T Stoyanova Molecular cancer therapeutics 18 (7), 1230-1242, 2019 | 50 | 2019 |
| Proliferation defects and genome instability in cells lacking Cul4A D Kopanja, T Stoyanova, MN Okur, E Huang, S Bagchi, P Raychaudhuri Oncogene 28 (26), 2456-2465, 2009 | 45 | 2009 |
